|
Volumn 26, Issue 1, 2006, Pages 113-114
|
Dr. Woodrow responds [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
'BALANCE';
GLUCOSE;
GLUCOSE DEGRADATION PRODUCT;
ICODEXTRIN;
PERITONEAL DIALYSIS FLUID;
ADVANCED GLYCATION END PRODUCT;
DIALYSIS FLUID;
BIOCOMPATIBILITY;
CLINICAL TRIAL;
DIALYSATE;
EVIDENCE BASED MEDICINE;
HEMODYNAMICS;
HUMAN;
KIDNEY FUNCTION;
LETTER;
OBSERVATIONAL STUDY;
OUTCOMES RESEARCH;
PERITONEAL DIALYSIS;
PERITONITIS;
PH MEASUREMENT;
PRIORITY JOURNAL;
SURVIVAL RATE;
CHEMISTRY;
CHRONIC KIDNEY FAILURE;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
KIDNEY;
MORTALITY;
NOTE;
PATHOPHYSIOLOGY;
PH;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
DIALYSIS SOLUTIONS;
GLYCOSYLATION END PRODUCTS, ADVANCED;
HUMANS;
HYDROGEN-ION CONCENTRATION;
KIDNEY;
KIDNEY FAILURE, CHRONIC;
PERITONEAL DIALYSIS;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 33745486168
PISSN: 08968608
EISSN: None
Source Type: Journal
DOI: 10.1177/089686080602600121 Document Type: Letter |
Times cited : (6)
|
References (4)
|